Thrombosis in congenital heart disease

Expert Rev Cardiovasc Ther. 2013 Dec;11(12):1579-82. doi: 10.1586/14779072.2013.854703.
No abstract available

Publication types

  • Comparative Study
  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Clinical Trials as Topic
  • Dose-Response Relationship, Drug
  • Fibrinolytic Agents / administration & dosage
  • Fibrinolytic Agents / adverse effects
  • Fibrinolytic Agents / therapeutic use*
  • Heart Defects, Congenital / complications
  • Heart Defects, Congenital / drug therapy*
  • Hemorrhage / chemically induced
  • Humans
  • Platelet Aggregation Inhibitors / administration & dosage
  • Platelet Aggregation Inhibitors / adverse effects
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Thrombosis / etiology
  • Thrombosis / prevention & control*
  • Treatment Outcome

Substances

  • Fibrinolytic Agents
  • Platelet Aggregation Inhibitors